Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 18F-4FMFES in Estrogen Receptor–Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial

Michel Paquette, Éric Lavallée, Serge Phoenix, René Ouellet, Helena Senta, Johan E. van Lier, Brigitte Guérin, Roger Lecomte and Éric E. Turcotte
Journal of Nuclear Medicine February 2018, 59 (2) 197-203; DOI: https://doi.org/10.2967/jnumed.117.194654
Michel Paquette
Sherbrooke Molecular Imaging Center, Research Center of the Sherbrooke University Hospital (CRCHUS), and Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Éric Lavallée
Sherbrooke Molecular Imaging Center, Research Center of the Sherbrooke University Hospital (CRCHUS), and Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serge Phoenix
Sherbrooke Molecular Imaging Center, Research Center of the Sherbrooke University Hospital (CRCHUS), and Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
René Ouellet
Sherbrooke Molecular Imaging Center, Research Center of the Sherbrooke University Hospital (CRCHUS), and Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helena Senta
Sherbrooke Molecular Imaging Center, Research Center of the Sherbrooke University Hospital (CRCHUS), and Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johan E. van Lier
Sherbrooke Molecular Imaging Center, Research Center of the Sherbrooke University Hospital (CRCHUS), and Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brigitte Guérin
Sherbrooke Molecular Imaging Center, Research Center of the Sherbrooke University Hospital (CRCHUS), and Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Lecomte
Sherbrooke Molecular Imaging Center, Research Center of the Sherbrooke University Hospital (CRCHUS), and Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Éric E. Turcotte
Sherbrooke Molecular Imaging Center, Research Center of the Sherbrooke University Hospital (CRCHUS), and Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 59 no. 2 197-203
DOI 
https://doi.org/10.2967/jnumed.117.194654
PubMed 
28798032

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication April 10, 2017
  • Accepted for publication June 26, 2017
  • Published online February 1, 2018.

Article Versions

  • previous version (August 10, 2017 - 08:56).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Michel Paquette,
  2. Éric Lavallée,
  3. Serge Phoenix,
  4. René Ouellet,
  5. Helena Senta,
  6. Johan E. van Lier,
  7. Brigitte Guérin,
  8. Roger Lecomte and
  9. Éric E. Turcotte
  1. Sherbrooke Molecular Imaging Center, Research Center of the Sherbrooke University Hospital (CRCHUS), and Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada
  1. For correspondence or reprints contact: Éric E. Turcotte, Nuclear Medicine and Radiobiology, Sherbrooke Molecular Imaging Center, 3001, 12th Ave., Sherbrooke, Québec, Canada, J1H 5N4. E-mail: eric.e.turcotte{at}usherbrooke.ca
View Full Text

Statistics from Altmetric.com

Cited By...

  • 34 Citations
  • 35 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
    George Crișan, Nastasia Sanda Moldovean-Cioroianu, Diana-Gabriela Timaru, Gabriel Andrieș, Călin Căinap, Vasile Chiș
    International Journal of Molecular Sciences 2022 23 9
  • Fluorine-containing pharmaceuticals approved by the FDA in 2020: Synthesis and biological activity
    Yingjie Yu, Aiyao Liu, Gagan Dhawan, Haibo Mei, Wei Zhang, Kunisuke Izawa, Vadim A. Soloshonok, Jianlin Han
    Chinese Chemical Letters 2021 32 11
  • Insight into the Development of PET Radiopharmaceuticals for Oncology
    Joseph Lau, Etienne Rousseau, Daniel Kwon, Kuo-Shyan Lin, François Bénard, Xiaoyuan Chen
    Cancers 2020 12 5
  • Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer
    Manoj Kumar, Kelley Salem, Amye J. Tevaarwerk, Roberta M. Strigel, Amy M. Fowler
    Journal of Nuclear Medicine 2020 61 2
  • Research progress of 18F labeled small molecule positron emission tomography (PET) imaging agents
    Mingliang Zhang, Shufeng Li, Hang Zhang, Haiwei Xu
    European Journal of Medicinal Chemistry 2020 205
  • Tumour functional imaging by PET
    Ana Margarida Abrantes, Ana Salomé Pires, Lúcia Monteiro, Ricardo Teixo, Ana Rita Neves, Nuno Tiago Tavares, Inês Alexandra Marques, Maria Filomena Botelho
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020 1866 6
  • Development of Radiotracers for Breast Cancer—The Tumor Microenvironment as an Emerging Target
    Amelie Heesch, Jochen Maurer, Elmar Stickeler, Mohsen Beheshti, Felix M. Mottaghy, Agnieszka Morgenroth
    Cells 2020 9 10
  • Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review
    Michele Balma, Virginia Liberini, Manuela Racca, Riccardo Laudicella, Matteo Bauckneht, Ambra Buschiazzo, Daniele Giovanni Nicolotti, Simona Peano, Andrea Bianchi, Giovanni Albano, Natale Quartuccio, Ronan Abgral, Silvia Daniela Morbelli, Calogero D'Alessandria, Enzo Terreno, Martin William Huellner, Alberto Papaleo, Désirée Deandreis
    Frontiers in Medicine 2022 9
  • Radiolabelled Aptamers for Theranostic Treatment of Cancer
    Umair Khalid, Chris Vi, Justin Henri, Joanna Macdonald, Peter Eu, Giovanni Mandarano, Sarah Shigdar
    Pharmaceuticals 2018 12 1
  • In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission Tomography
    Yuta Takamura, Hiroki Kakuta
    Journal of Medicinal Chemistry 2021 64 9

Article usage

Article usage: August 2017 to April 2025

AbstractFullPdf
Aug 2017517027
Sep 2017229011
Oct 201710807
Nov 201757011
Dec 20172905
Jan 201834023
Feb 201814572886
Mar 20183491127
Apr 20181711119
May 2018108110
Jun 2018741410
Jul 20188316
Aug 201880513
Sep 2018801115
Oct 201848610
Nov 2018544420
Dec 2018391715
Jan 2019601311
Feb 2019521319
Mar 2019452428
Apr 2019512326
May 2019421720
Jun 2019341720
Jul 2019412620
Aug 2019202116
Sep 2019381520
Oct 2019291521
Nov 2019251815
Dec 2019241610
Jan 2020282017
Feb 2020161632
Mar 2020201515
Apr 2020412027
May 2020363815
Jun 202020124
Jul 202016135
Aug 2020121712
Sep 202016479
Oct 2020201711
Nov 2020152111
Dec 202019183
Jan 2021124017
Feb 2021105016
Mar 202154913
Apr 202153318
May 202194025
Jun 2021193013
Jul 2021104737
Aug 202191718
Sep 2021133512
Oct 202194029
Nov 2021113524
Dec 202182313
Jan 2022112910
Feb 202211257
Mar 2022134831
Apr 2022103421
May 202254319
Jun 202271814
Jul 202262110
Aug 202253523
Sep 202271919
Oct 20224148
Nov 202232015
Dec 20226169
Jan 2023122920
Feb 202382013
Mar 202384221
Apr 202341112
May 20236614
Jun 20237218
Jul 202363013
Aug 20236118
Sep 20233109
Oct 20230124
Nov 202361415
Dec 202342514
Jan 20242338
Feb 20241188
Mar 20245421
Apr 202494524
May 2024123221
Jun 20244189
Jul 2024202231
Aug 202453523
Sep 202434419
Oct 202473518
Nov 202451415
Dec 20244164
Jan 202512425
Feb 2025118819
Mar 2025123828
Apr 202552524
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 59 (2)
Journal of Nuclear Medicine
Vol. 59, Issue 2
February 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 18F-4FMFES in Estrogen Receptor–Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 18F-4FMFES in Estrogen Receptor–Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial
Michel Paquette, Éric Lavallée, Serge Phoenix, René Ouellet, Helena Senta, Johan E. van Lier, Brigitte Guérin, Roger Lecomte, Éric E. Turcotte
Journal of Nuclear Medicine Feb 2018, 59 (2) 197-203; DOI: 10.2967/jnumed.117.194654

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 18F-4FMFES in Estrogen Receptor–Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial
Michel Paquette, Éric Lavallée, Serge Phoenix, René Ouellet, Helena Senta, Johan E. van Lier, Brigitte Guérin, Roger Lecomte, Éric E. Turcotte
Journal of Nuclear Medicine Feb 2018, 59 (2) 197-203; DOI: 10.2967/jnumed.117.194654
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • 18F-4FMFES and 18F-FDG PET/CT in Estrogen Receptor-Positive Endometrial Carcinomas: Preliminary Report
  • ER Imaging for Estrogen-Related Tumors Is Bothersome but Useful
  • Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer
  • Google Scholar

More in this TOC Section

Oncology

  • Role of F18-FDG PET/CT in non-cutaneous melanomas.
  • The role of Lymphoscintigraphy in Breast Cancer Reccurence
  • Utility of bone scans in patients with RCC
Show more Oncology

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • Receptor PET imaging
  • ER+
  • breast cancer
  • 18F-FES
  • 18F-4FMFES
SNMMI

© 2025 SNMMI

Powered by HighWire